📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Tyrosine kinase inhibitor sunitinib allows insulin independence in long-standing type 1 diabetes. (2014)

First Author: Huda MS

Attributed to: MRC Centre for Transplantation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2337/dc13-2132

PubMed Identifier: 24757248

Publication URI: http://europepmc.org/abstract/MED/24757248

Type: Journal Article/Review

Volume: 37

Parent Publication: Diabetes care

Issue: 5

ISSN: 0149-5992